News for Blade Air Mobility, Inc. (BLDE)

**media[546940]**

We recently published a list of 12 Best Airport Stocks to Invest in Now. In this article, we are going to take a look at where Blade Air Mobility, Inc.

The electric vertical takeoff and landing (eVTOL) sector experienced a downturn, with Archer Aviation (ACHR) dropping over 9%, Joby Aviation (JOBY) falling more

On January 7, 2025, William Heyburn, the Chief Financial Officer of Blade Urban Air Mobility, a subsidiary of Blade Air Mobility Inc (BLDE), sold 104,570 shares

NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. ( BLDE, ”œBlade” or the ”œCompany”), a technology-powered air mobility platform, to

Critical Role of Vibration Mitigation in Safety and Comfort of Helicopter Operations

Blade Air Mobility is shifting focus to organ transportation for strong growth and profitability in the medical segment. See why I rate BLDE stock a buy now.

Blade Air Mobility CFO William Heyburn sells $197,018 in stock

On December 4, 2024, Amir Cohen, the Chief Accounting Officer of Blade Urban Air Mobility, a subsidiary of Blade Air Mobility Inc (BLDE), sold 10,150 shares of

Blade Air Mobility's chief accounting officer sells $45,225 in stock

On November 29, 2024, Melissa Tomkiel, President and General Counsel of Blade Urban Air Mobility, a branch of Blade Air Mobility Inc (BLDE), sold 111,377 shares

BLDE stock soars to 52-week high, touches $4.25

Cathie Wood's ARK ETF shifts focus with major stock trades in AMD and TER

Cathie Wood's ARK makes major plays in Recursion, Twist Bioscience stock

Cathie Wood's ARK buys ARCT, TXG, and sells VEEV, EXAS stock

Wheels Up Experience Inc (UP), a key player in the transportation sector, has experienced a notable fluctuation in its stock price recently. Over the past week,

Wheels Up Experience Inc (UP) has recently demonstrated a notable performance in the stock market with a significant 74.57% increase over the past week and a 15

Blade Air Mobility executive sells over $13k in company stock

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and board changes. Lifecore Biomedical shares dipped 31.7% to $4.91 on Wednesday.